Resultados de la búsqueda 291-300 of 3917 for Incidence

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...

  2. Ensayos clínicos - Neurología

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  3. Oncología (médica) - Ensayos clínicos

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  4. Ensayos clínicos - Neurología

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  5. Ensayos clínicos - Neurología

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  6. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  7. Oncología (médica) - Ensayos clínicos

    A Study to Assess Endometrial Cancer Recurrence in Patients After 36 Months. Rochester, Minn. The purpose of this study is to assess the 36-month incidence of ...

  8. Neurología - Ensayos clínicos

    This study aims to evaluate the safety of local delivery of AMSCs for recurrent GBM by noting the incidence of adverse events, as well as radiological and ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study to Assess Endometrial Cancer Recurrence in Patients After 36 Months. Rochester, Minn. The purpose of this study is to assess the 36-month incidence of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the 1-year cumulative incidence of severe GVHD (from day of HCT) defined as Grade III-IV acute GVHD (aGVHD) and/or ...